Friday 27 September 2013

07:45 - 08:45

Free Papers (main auditorium)

Chairs: Sebastian Roka (Austria), Ethem Gecim (Turkey)

• F13: Can apparent diffusion coefficient (ADC) on diffusion weighted MRI predict tumour aggressiveness in rectal cancer? - Khawar Hashmi (Barnet General Hospital, UK)
• F14: ANACO: Spanish study on ANAstomotic leak after COlon resection for cancer. Results of a multicentric, national, prospective, observational study including 3193 patients - Matteo Frasson (University Hospital La Fe, Spain)
• F15: Local vs rectal excision in downstaged low rectal cancer after radiochemotherapy: preliminary results of the randomized GRECCAR 2 trial - Eric Rullier (Saint-André Hospital, France)
• F16: Sexual and urinary function after open and laparoscopic rectal cancer surgery in the COLOR II trial - John Andersson (Scandinavian Surgical Outcomes Research Group (SSORG), Sweden and Dep. of Surgery, Sweden)
• F17: Examining the impact of using 90-day rather than 30-day mortality rates for identifying poor performing surgical providers in colorectal surgery: a population-based cohort study - Ben Byrne (Imperial College, UK)
• F18: RT-PCR of escherichia coli in drain fluid: the first screening test for symptomatic colorectal anastomotic leakage - Niels Komen (University Medical Center Rotterdam, The Netherlands)

Free Papers (parallel auditorium)

Chairs: Filippo La Torre (Italy), Joao Pimentel (Portugal)

• F19: Sacral neuromodulation: the effect of stimulation frequency on inputs to the somatosensory cortex in a rat model - Judith Evers (School of Medicine and Medical Science, University College Dublin, Ireland)
• F20: Biofeedback - a simple and effective way of managing rectal evacuatory dysfunction secondary to pelvic floor dyssynergia and rectal hyposensitivity - Craig Rimmer (Sandwell and West Birmingham Hospitals NHS Trust, UK)
• F21: Functional quality of the anal sphincter five years after intensified radiochemotherapy in patients with locally advanced rectal cancer - Karoline Horisberger (University Hospital of Mannheim, Germany)
• F22: Percutaneous tibial nerve stimulation (PTNS) for faecal incontinence (FI): does it last? - Alexander Hotouras (Academic Surgical Unit, National Centre for Bowel Research and Surgical Innovation, Barts Health NHS Trust, UK)
• F23: Double blinded randomized controlled trial of collagen mesh for prevention of ventral hernia in patients with vertical rectus Abdominis Myocutaneus (VRAM) Flap - Peter Christensen (Aarhus University Hospital, Denmark)
• F24: Abnormal glycaemic control and derangement of the renin-angiotensin-aldosterone system after colectomy - Sreelakshmi Mallappa (The Polyposis Registry, St Mark's Hospital, UK)

08:45 - 09:15

Keynote/ASCRS Lecture: Modern treatment of appendicitis (main auditorium)

Chair: Søren Laurberg (Denmark)

Speaker: Michael J Stamos (USA)

Award for Best of the Six Best and ESCP Fellowship Update (main auditorium)

Symposium: Update on Crohn's Disease (main auditorium)

Chairs: Willem Bemelman (The Netherlands), Yehiel Ziv (Israel)

• Can medical treatment change the natural course of Crohn's disease? - Njegica Jojic (Serbia)
• Surgery for recurrent Crohn's disease - Neil Mortensen (UK)
• Surgical management of severe colorectal Crohn's disease - Gianluca Sampietro (Italy)

11:00 - 12:30

Consultants’ Corner (main auditorium)

Convenors: Najib Haboubi (UK), Stefan Post (Germany)

Panel: Michael J Stamos (USA), Adam Dziki (Poland), Frank Frizelle (New Zealand), Sebastiano Biondo (Spain), Giovanni Romano (Italy), Evgeny Rybakov (Russia)

12:30 - 12:40

EBSQ Examination Awards (main auditorium)

12:40 - 14:20

14:20 - 15:20

Free Papers (main auditorium)

Chairs: Paris Tekkis (UK), Ints Brunenieks (Latvia)

• F25: Bilateral sacral nerve stimulation for idiopathic faecal incontinence - results of a randomize single blind cross-over-study - Jakob Duelund-Jakobsen (Surgical Research Unit, Department of Surgery P, Aarhus University Hospital, Tage-Hansens Gade, Denmark)
• F26: Isosorbide dinitrate ointment versus botulinum toxin A (Dysport®) as primary treatment for chronic anal fissure: a randomized multicenter study - A.E.M. Berkel (Medisch Spectrum Twente, The Netherlands)
• F27: Progress or regress? Natural history of anal dysplasia in HIV-infected patients - Laurent Siproudhis (CHU Pontchaillou, France and Université Rennes 1, France)
• F28: Epsit: endoscopic pilonidal sinus treatment - Lorenzo Mori (Department of General Surgery, Proctological Unit - Azienda Sanitaria Locale No. 4 Chiavarese, Italy)
• F29: A randomized clinical trial comparing biodesign® AFP to advancement flap for the repair of anal fistulas: interim results - Thilo Schwandner (Department of General & Thoracic Surgery, University Hospital Gießen, Germany)
• F30: Three-dimensional endoanal ultrasonography and fistuloscopy in the diagnosis recurrent perianal fistulas: a comparative study - Alessandro Stazi (Department of Surgery, Casa di Cura Madonna delle Grazie, Velletri Rome, Italy)

Free Papers (parallel auditorium)

Chairs: Marc Duinslaeger (Belgium), Istvan Besznyak (Hungary)

• F31: Rectal cancer surgery after high dose radiotherapy for prostate cancer: is sphincter preservation relevant? - Etienne Buscail (Saint-André Hospital, France)
• F32: Renal function remains significantly deranged 3 months after anterior resection when a defunctioning loop ileostomy is used rather than a loop colostomy - Ayaz Vantra (The Royal Shrewsbury Hospital, UK)
• F33: Effect of anti-tumor necrosis factor alpha agents on postoperative anastomotic complications in Crohn’s disease: a systematic review - Alaa El-Hussuna (Copenhagen University, Denmark)
• F34: Does intramesorectal proctectomy (IMP) provide improved outcomes compared to standard total mesorectal excision (TME) in patients with ulcerative colitis (UC)? - Liliana Bordeianou (Massachusetts General Hospital, USA)
• F35: Laparoscopic approach for inflammatory bowel disease is a real alternative to open surgery: an experience in 790 consecutive patients - Léon Maggiori (Beaujon Hospital, France)
• F36: Do perianal Crohn's fistulae arise from the gut? - Nuha Yassin (St Mark's Hospital, UK and APRG - Imperial College London, UK)

15:20 - 15:50

Keynote Lecture: Neoadjuvant treatment in colon cancer (main auditorium)

Chair: Lars Påhlman (Sweden)

Speaker: Dion Morton (UK)

15:50 - 16:00

Honorary Member and Best Lunchtime Poster Awards

16:00 - 16:45

Oral Posters (main auditorium)

Chairs: Jean-Luc Faucheron (France), Volodymyr Andriets (Ukraine)

• OP43: Myopenia and the systemic inflammatory response in patients with operable colorectal cancer - George Malietzis (Department of Colorectal Surgery, St Mark's Hospital, UK)
• OP44: Supraconal spinal cord injury (SCI) significantly impairs colorectal emptying during defecation - Peter Christensen (Department of Surgery, Aarhus University Hospital, Denmark)
• OP45: External validation of the GENEVA-COLA score for predicting surgical site infection after colorectal surgery - Patricia Sánchez (Hospital del Mar, Spain)
• OP46: Long term clinical outcome of right-sided colonic diverticulitis - Hyoung-chul Park (Hallym University Sacred Heart Hospital, Republic of Korea)
• OP47: What is reduced port surgery trying to reduce? a prospective evaluation of trocar related morbidity - Alessandra Cristaudi (Centre Hospitalier Universitaire Vaudois, Switzerland)
• OP48: Systematic review of the natural history of left-sided acute diverticulitis treated conservatively - J.E.F. Fitzgerald (Chelsea & Westminster Hospital, UK)
• OP49: Risk factors for rebleeding and urgent operation in patients with diverticular hemorrhage - Hayim Gilshtein (Rambam Health Care Campus, Israel)
• OP50: Consultant versus trainee-led outcomes in colorectal resection: a systematic review and meta-analysis - Michael Kelly (Imperial College, UK)
• OP51: A methodology for measuring institutional performance in colorectal surgery in the international setting - Aruna Munasinghe (Imperial College London, UK)

Oral Posters (parallel auditorium)

Chairs: Hartwig Korner (Norway), Marek Szczepkowski (Poland)

• OP52: Restorative proctocolectomy (RPC) for ulcerative colitis (UC): development and validation of a new scoring system for pouch dysfunction and quality of life (QoL) - Søren Brandsborg (Aarhus University Hospital, Denmark)
• OP53: Postoperative complications are not influenced by a prolonged nutritional support in patients operating on for a perforating Crohn's disease - Emilie Duchalais (Digestive and Endocrine Surgery department, University Hospital, France)
• OP54: Risk factors of permanent stoma in surgically treated patients with Crohn's disease - Seonok Oh (Asan Medical Center, Republic of Korea)
• OP55: A meta-analysis of laparoscopic resection for recurrent Crohn's disease - Kohei Shigeta (Saitama City Hospital, Department of Surgery, Japan)
• OP56: Risk factors of advancement flap healing failure and fistula recurrence in IBD patients with perianal disease - Zuzana Serclova (Central Military Hospital, Czech Republic)
• OP57: Fistulising and stricturing ileocaecal Crohn's disease: Is there a difference? - Heena Patel (St. Mark's Hospital, UK)
• OP58: Failed colorectal or coloanal anastomosis with chronic pelvic sepsis or rectovaginal fistula: Transanal colonic pull-through with delayed coloanal anastomosis is associated with a high success rate - Julien Blanche (Beaujon Hospital, France)
• OP59: Bioprosthetic mesh for the prevention of incisional hernia during ileostomy closure in rectal cancer patients: a first case-control study - David Moszkowicz (Beaujon Hospital, France)
• OP60: Peripheral nerve injury after open and laparoscopic colorectal surgery - Pierpaolo Sileri (University of Tor Vergata, Italy)

Symposium: Diverticular Disease (main auditorium)

Chairs: Goran Stanojevic (Serbia), Dieter Hahnloser (Switzerland)

• Natural history - Pascal Gervaz (Switzerland)
• Emergency surgery - Tom Oresland (Norway)
• Long term outcomes - Gian Andrea Binda (Italy)

17:45